Compare EHTH & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | CTSO |
|---|---|---|
| Founded | 1997 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 23.9M |
| IPO Year | 2006 | 2008 |
| Metric | EHTH | CTSO |
|---|---|---|
| Price | $0.37 | $4.50 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | $1.58 | ★ $47.50 |
| AVG Volume (30 Days) | ★ 507.6K | 36.3K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | 65.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $251,395,000.00 | $22,503,908.00 |
| Revenue This Year | N/A | $4.91 |
| Revenue Next Year | $3.04 | $13.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 45.86 | ★ 48.53 |
| 52 Week Low | $0.37 | $0.30 |
| 52 Week High | $5.35 | $7.44 |
| Indicator | EHTH | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 28.32 | 47.79 |
| Support Level | N/A | $2.88 |
| Resistance Level | $0.69 | $7.20 |
| Average True Range (ATR) | 0.06 | 0.65 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 2.96 | 33.26 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.